BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Prognosis
9012 results:

  • 1. The interrelationship between obesity and race in breast cancer prognosis: a prospective cohort study.
    Schindler EA; Takita C; Collado-Mesa F; Reis IM; Zhao W; Yang GR; Acosta LG; Hu JJ
    BMC Womens Health; 2024 May; 24(1):312. PubMed ID: 38816709
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
    Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Analysis of the Expression, prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in breast Tumor.
    Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA
    Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients.
    Perelmuter VM; Grigoryeva ES; Savelieva OE; Alifanov VV; Andruhova ES; Zavyalova MV; Bragina OD; Garbukov EY; Menyailo ME; Khozyainova AA; Denisov EV; Cherdyntseva NV; Tashireva LA
    Sci Rep; 2024 May; 14(1):12245. PubMed ID: 38806508
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity.
    Püsküllüoğlu M; Grela-Wojewoda A; Ambicka A; Pacholczak-Madej R; Pietruszka A; Mucha-Małecka A; Rudzińska A; Ziobro M; Ryś J; Mituś JW
    Front Endocrinol (Lausanne); 2024; 15():1217495. PubMed ID: 38800480
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Fei F; Caporale C; Chang L; Fortini BK; Ali H; Bell D; Stein A; Marcucci G; Telatar M; Afkhami M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791222
    [No Abstract]    [Full Text] [Related]  

  • 7. Pectinose induces cell cycle arrest in luminal A and triple-negative breast cancer cells by promoting autophagy through activation of the p38 MAPK signaling pathway.
    Yu S; Yue Z; Liu Q
    BMC Cancer; 2024 May; 24(1):639. PubMed ID: 38789954
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hypermethylation of the Gene Body in
    Shen HT; Hung CS; Davis C; Su CM; Liao LM; Shih HM; Lee KD; Ansar M; Lin RK
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785978
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
    He ZX; Li J; Wang QF; Cheng Q; Ni SJ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
    [No Abstract]    [Full Text] [Related]  

  • 10. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
    Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
    [No Abstract]    [Full Text] [Related]  

  • 11. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
    Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
    Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.
    Wang J; Yu Y; Tan Y; Wan H; Zheng N; He Z; Mao L; Ren W; Chen K; Lin Z; He G; Chen Y; Chen R; Xu H; Liu K; Yao Q; Fu S; Song Y; Chen Q; Zuo L; Wei L; Wang J; Ouyang N; Yao H
    Nat Commun; 2024 May; 15(1):4369. PubMed ID: 38778014
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prevention of persistent pain with lidocaine infusions in breast cancer surgery (PLAN): study protocol for a multicenter randomized controlled trial.
    Khan JS; Gilron I; Devereaux PJ; Clarke H; Ayach N; Tomlinson G; Quan ML; Ladha KS; Choi S; Munro A; Brull R; Lim DW; Avramescu S; Richebé P; Hodgson N; Paul J; McIsaac DI; Derzi S; Zbitnew GL; Easson AM; Siddiqui NT; Miles SJ; Karkouti K;
    Trials; 2024 May; 25(1):337. PubMed ID: 38773653
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer.
    Hao Y; Zhang X; Cui G; Qi X; Jiang Z; Yu L
    Cancer Med; 2024 May; 13(10):e7296. PubMed ID: 38770671
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
    Qi G; Zhang X; Gai X; Yan X
    PeerJ; 2024; 12():e17377. PubMed ID: 38766488
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. D-arabinose induces cell cycle arrest by promoting autophagy via p38 MAPK signaling pathway in breast cancer.
    Tang Z; Song H; Qin S; Tian Z; Zhang C; Zhou Y; Cai R; Zhu Y
    Sci Rep; 2024 May; 14(1):11219. PubMed ID: 38755221
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A meta-analysis of randomized controlled trials comparing breast-conserving surgery and mastectomy in terms of patient survival rate and quality of life in breast cancer.
    Li S; Li X; Li D; Zhao Q; Zhu L; Wu T
    Int J Qual Health Care; 2024 May; 36(2):. PubMed ID: 38753325
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CircAGFG1 Promotes Ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
    Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
    Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Patterns of distant metastasis and survival outcomes in
    Liu K; Huang AL; Chen XQ; Wu SG
    Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. circATAD2 mitigates CD8
    Zhang Z; Huo W; Li J
    Cancer Immunol Immunother; 2024 May; 73(7):130. PubMed ID: 38748254
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 451.